戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 giitis that would have obviated the need for brain biopsy.
2 uld allow some patients to avoid the risk of brain biopsy.
3 on initial type of encephalitis diagnosed by brain biopsy.
4  performed high-throughput RNA sequencing on brain biopsy.
5 sy, 5 of them underwent surgery, and 1 had a brain biopsy.
6 phalopathy (PML) was ultimately confirmed by brain biopsy.
7  of samples is available as is the case with brain biopsy.
8 iagnoses, which emphasizes the importance of brain biopsy.
9  by microscopic examination and culture of a brain biopsy.
10  extensive conventional testing, including a brain biopsy.
11 dmission and before a CT-guided stereotactic brain biopsy.
12  of sampling error that plagues conventional brain biopsy.
13 ction and recycling in human fibroblasts and brain biopsies.
14 tivity to the ethnic backgrounds or areas of brain biopsies.
15 nts and thus obviate the need for diagnostic brain biopsies.
16 e observed increased VGF levels in serum and brain biopsies.
17      None had primary angiitis of the CNS at brain biopsy (60% specificity).
18 hallenges associated with the acquisition of brain biopsies add compounding difficulties to exploring
19     We analyzed axonal pathology in archival brain biopsy and autopsy samples from 19 children with e
20 zed 37 full-length env genes from uncultured brain biopsy and blood samples from four patients with A
21                                              Brain biopsy and cerebrospinal fluid polymerase chain re
22 (n = 13; median age 43 years, range 5-67) on brain biopsy and/or autopsy, ascertained retrospectively
23 e present the clinical, imaging, laboratory, brain biopsy, and autopsy findings of a 57-year-old male
24 nopathologic patterns of MS as determined by brain biopsy, and we identified unique antibody patterns
25                                              Brain biopsies are often not feasible as a result of coa
26 sis in patients with lesions not amenable to brain biopsy, as well as provide improved surrogates of
27 der mechanical ventilation undergoing in-ICU brain biopsy between January 2008 and October 2020 were
28         The gold standard for diagnosis is a brain biopsy, but more often the response to treatment s
29       Genotyping of somatic cells as well as brain biopsies confirmed mutations in the SHANK3 gene an
30                                              Brain biopsy confirmed active, T-cell type MS.
31                                In 1 patient, brain biopsy demonstrated axonal spheroids and pigmented
32                           Diagnosis requires brain biopsy for confirmation and is suggested prior to
33 rt of patients at a single center undergoing brain biopsy for non-oncologic indications.
34 mortem diagnosis of prion disease depends on brain biopsy for prion detection currently and no valida
35  for mimicking diagnoses before performing a brain biopsy for suspected small vessel primary angiitis
36  various in vitro conditions, and from human brain biopsies, for unbiased multiomic analysis.
37 letion (STED) super-resolution microscopy of brain biopsies from patients who died of pneumococcal me
38 died patients with encephalitis diagnosed by brain biopsy from January 1, 1983, through December 31,
39                                              Brain biopsy has an uncertain role in the diagnosis of d
40 and signs of hypomyelination, and gliosis on brain biopsy in another patient.
41                                              Brain biopsy in critically ill patients with neurologic
42 ibility, safety, and the diagnostic yield of brain biopsy in critically ill patients with neurologic
43 d compare the safety and diagnostic value of brain biopsy in HIV patients in the pre-highly active an
44                                              Brain biopsy in HIV patients is safe with high diagnosti
45 tic procedures that may obviate the need for brain biopsy in the future.
46                                  Findings of brain biopsy in the remaining eight patients were nondia
47 to those of non-ICU patients who underwent a brain biopsy in the same clinical context.
48                    The benefit/risk ratio of brain biopsy in this population should be carefully weig
49                                              Brain biopsy is a useful surgical procedure in the manag
50                           Thus, a diagnostic brain biopsy is not warranted in these patients.
51 tion (qPCR) in cerebrospinal fluid (CSF), or brain biopsy, is required for probable or definite diagn
52 pheral blood, cerebrospinal fluid (CSF), and brain biopsy material derived from MS patients and contr
53                                        Early brain biopsy may be indicated in HIV patients with focal
54 cumstances, an important role for diagnostic brain biopsy may be required in some cases.
55                              Angiography and brain biopsy may complement each other when determining
56                                     Positive brain biopsies occurred in 10% of patients.
57                  Expression of CXCL13 in the brain biopsy of a patient with anti-NMDAR encephalitis w
58  immune responses, previously attainable via brain biopsy only.
59 llowing withdrawal, and PML was confirmed by brain biopsy or by identifying JC virus in the cerebrosp
60 101 consecutive patients with PCNSV based on brain biopsy or conventional angiography (or both) betwe
61 py or cell transduction without the need for brain biopsy or necroscopy.
62 n vivo, which until recently required either brain biopsy or PET imaging with an on-site cyclotron an
63 id JC virus (JCV) polymerase chain reaction, brain biopsy, or autopsy, and who had MR images availabl
64                              Among the 2,207 brain-biopsied patients during the study period, 234 bio
65                                              Brain biopsies revealed inflammatory encephalitis associ
66                             Skin, liver, and brain biopsies revealed vasculopathic changes characteri
67                                              Brain biopsy revealed typical features of PML as well as
68 ourth patient, still alive, was diagnosed by brain biopsy) revealed changes affecting predominantly t
69 d recurrent aseptic meningitis and underwent brain biopsy revealing a diagnosis of neurosarcoidosis.
70  be diagnosed, which obviates the need for a brain biopsy sample to be taken.
71  on a dataset that is comprised of 646 human brain biopsy samples from 60 different patients.
72 Last, we observed TREM1(+) cells in clinical brain biopsy samples from two treatment-naive patients w
73 oluble aggregates in the cortical area of LD brain biopsy samples, and there is also a dramatic loss
74 essing FAK in vitro but not in nonneoplastic brain biopsy samples.
75                                        Early brain biopsy should be considered in patients without cl
76          Next-generation sequencing (NGS) or brain biopsy should be considered.
77                  Immunohistochemistry of the brain biopsy showed positive neuronal staining.
78 d the second option is Western blotting of a brain biopsy specimen used to detect protease-resistant
79 any presence of CAA from routinely collected brain biopsy specimen, biopsy specimen at hematoma evacu
80 s not detected in normal human brain, all 24 brain biopsy specimens containing PCNSL were positive fo
81 emistry on formalin-fixed, paraffin-embedded brain biopsy specimens from 24 patients with PCNSL to in
82 rectly, we undertook a morphometric study of brain biopsy specimens from AD and control cases.
83 ransfected with human PS1 complementary DNA, brain biopsy specimens from demented patients, and postm
84           Cerebrospinal fluid analysis and 2 brain biopsy specimens showed no evidence of an infectio
85                                              Brain biopsy specimens that exhibit encephalitis without
86 AA were included: 52 with autopsies, 22 with brain biopsy specimens, and 31 with pathologic samples f
87 e human gene expression patterns in 30 human brain biopsy specimens.
88                        Patient demographics, brain biopsy technique, histopathology and patient outco
89 malignancies traditionally involves invasive brain biopsies that pose significant risk to the patient
90            Compared with nonneoplastic adult brain biopsies, the levels of FAK protein are elevated a
91 olymerase chain reaction and sequencing from brain biopsy tissue collected 33 months antemortem, conf
92 on sequencing of his cerebrospinal fluid and brain biopsy tissue was performed to identify a causativ
93 istochemistry for free-living amoebas on the brain biopsy tissue were positive.
94 ed the presence of Cache Valley virus in the brain biopsy tissue.
95  patients (of 109; 12%) had undergone repeat brain biopsy to confirm PCNSL.
96 al testing (conjunctival, transbronchial and brain biopsies) to search for causes of an inflammatory
97  symptoms, laboratory studies, neuroimaging, brain biopsy, treatment, and complications were recorded
98        Median time from onset of symptoms to brain biopsy was 66 days (interquartile range, 18-135 da
99                  Diagnostic workup including brain biopsy was unrevealing.
100              The most common indications for brain biopsy were diagnosis unlikely to be toxoplasmosis
101  in symptomatic individuals, compared to the brain biopsy Western blot sensitivity of 20 to 60%.
102 useful in guiding the decision to proceed to brain biopsy where a treatable disease cannot be exclude

 
Page Top